Published in Clin Res Cardiol on December 11, 2009
Cardiac alpha-myosin (MYH6) is the predominant sarcomeric disease gene for familial atrial septal defects. PLoS One (2011) 0.93
A novel GATA4 loss-of-function mutation associated with congenital ventricular septal defect. Pediatr Cardiol (2011) 0.91
Combined cardiological and neurological abnormalities due to filamin A gene mutation. Clin Res Cardiol (2010) 0.86
Congenital heart disease: the crossroads of genetics, epigenetics and environment. Curr Genomics (2014) 0.85
A Comprehensive In Silico Analysis on the Structural and Functional Impact of SNPs in the Congenital Heart Defects Associated with NKX2-5 Gene-A Molecular Dynamic Simulation Approach. PLoS One (2016) 0.80
Novel GATA4 mutations in patients with congenital ventricular septal defects. Med Sci Monit (2012) 0.80
CCN1 mutation is associated with atrial septal defect. Pediatr Cardiol (2014) 0.78
A novel variant in TBX20 (p.D176N) identified by whole-exome sequencing in combination with a congenital heart disease related gene filter is associated with familial atrial septal defect. J Zhejiang Univ Sci B (2014) 0.77
c.620C>T mutation in GATA4 is associated with congenital heart disease in South India. BMC Med Genet (2015) 0.77
Relationship between atrial septal aneurysms and atrial electromechanical delay. Int J Cardiovasc Imaging (2010) 0.76
Congenital heart defects are rarely caused by mutations in cardiac and smooth muscle actin genes. Biomed Res Int (2015) 0.76
Mild decrease in TBX20 promoter activity is a potentially protective factor against congenital heart defects in the Han Chinese population. Sci Rep (2016) 0.76
Cardiac Embryology and Molecular Mechanisms of Congenital Heart Disease: A Primer for Anesthesiologists. Anesth Analg (2016) 0.75
Genetic mutation analysis in Japanese patients with non-syndromic congenital heart disease. J Hum Genet (2015) 0.75
Association Between the 4p16 Susceptibility Locus and the Risk of Atrial Septal Defect in Population from Southeast China. Pediatr Cardiol (2015) 0.75
Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis. Genes Dev (1997) 6.52
GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature (2003) 6.40
Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science (1998) 5.98
A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease. Cell (2001) 5.77
Myogenic and morphogenetic defects in the heart tubes of murine embryos lacking the homeo box gene Nkx2-5. Genes Dev (1995) 5.53
Building the mammalian heart from two sources of myocardial cells. Nat Rev Genet (2005) 5.51
Congenital heart disease in the general population: changing prevalence and age distribution. Circulation (2007) 5.16
Mutations in human TBX5 [corrected] cause limb and cardiac malformation in Holt-Oram syndrome. Nat Genet (1997) 5.11
Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family. Nat Genet (1997) 4.92
Familial heart disease with skeletal malformations. Br Heart J (1960) 4.76
Long-term outcome after surgical repair of isolated atrial septal defect. Follow-up at 27 to 32 years. N Engl J Med (1990) 4.70
The developmental genetics of congenital heart disease. Nature (2008) 4.61
TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell (2001) 4.60
Role of TBX1 in human del22q11.2 syndrome. Lancet (2003) 4.45
Nkx-2.5: a novel murine homeobox gene expressed in early heart progenitor cells and their myogenic descendants. Development (1993) 3.94
Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study. Lancet (1998) 3.03
Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways. J Clin Invest (1999) 2.95
Cardiac septal and valvular dysmorphogenesis in mice heterozygous for mutations in the homeobox gene Nkx2-5. Circ Res (2000) 2.82
Different TBX5 interactions in heart and limb defined by Holt-Oram syndrome mutations. Proc Natl Acad Sci U S A (1999) 2.70
Cardiac malformations, adrenal agenesis, neural crest defects and exencephaly in mice lacking Cited2, a new Tfap2 co-activator. Nat Genet (2001) 2.60
Submicroscopic chromosomal imbalances detected by array-CGH are a frequent cause of congenital heart defects in selected patients. Eur Heart J (2007) 2.39
A gain-of-function TBX5 mutation is associated with atypical Holt-Oram syndrome and paroxysmal atrial fibrillation. Circ Res (2008) 2.39
Proper coronary vascular development and heart morphogenesis depend on interaction of GATA-4 with FOG cofactors. Genes Dev (2001) 2.32
Mutation in the alpha-cardiac actin gene associated with apical hypertrophic cardiomyopathy, left ventricular non-compaction, and septal defects. Eur Heart J (2007) 2.14
NKX2.5 mutations in patients with congenital heart disease. J Am Coll Cardiol (2003) 2.09
GATA4 sequence variants in patients with congenital heart disease. J Med Genet (2007) 2.08
Mutations in cardiac T-box factor gene TBX20 are associated with diverse cardiac pathologies, including defects of septation and valvulogenesis and cardiomyopathy. Am J Hum Genet (2007) 1.97
NKX2.5 mutations in patients with tetralogy of fallot. Circulation (2001) 1.96
Management of grown up congenital heart disease. Eur Heart J (2003) 1.94
T-box genes coordinate regional rates of proliferation and regional specification during cardiogenesis. Development (2005) 1.92
GATA-4 is a novel transcription factor expressed in endocardium of the developing heart. Development (1993) 1.91
Murine T-box transcription factor Tbx20 acts as a repressor during heart development, and is essential for adult heart integrity, function and adaptation. Development (2005) 1.90
Cardiac T-box factor Tbx20 directly interacts with Nkx2-5, GATA4, and GATA5 in regulation of gene expression in the developing heart. Dev Biol (2003) 1.89
Cardiac homeobox gene NKX2-5 mutations and congenital heart disease: associations with atrial septal defect and hypoplastic left heart syndrome. J Am Coll Cardiol (2003) 1.86
Recurrence of congenital heart defects in families. Circulation (2009) 1.85
Tbx20 dose-dependently regulates transcription factor networks required for mouse heart and motoneuron development. Development (2005) 1.82
Mutation in myosin heavy chain 6 causes atrial septal defect. Nat Genet (2005) 1.76
Sarcomeric proteins and inherited cardiomyopathies. Cardiovasc Res (2007) 1.75
Spectrum of heart disease associated with murine and human GATA4 mutation. J Mol Cell Cardiol (2007) 1.71
T-box transcription factors and their roles in regulatory hierarchies in the developing heart. Development (2005) 1.70
Phenotypes with GATA4 or NKX2.5 mutations in familial atrial septal defect. Am J Med Genet A (2005) 1.69
Signaling pathways controlling second heart field development. Circ Res (2009) 1.67
Transcription factors and congenital heart defects. Annu Rev Physiol (2006) 1.66
A novel mutation in the GATA4 gene in patients with Tetralogy of Fallot. Hum Mutat (2006) 1.64
Tbx20 is essential for cardiac chamber differentiation and repression of Tbx2. Development (2005) 1.61
Natural history of secundum atrial septal defect in adults after medical or surgical treatment: a historical prospective study. Br Heart J (1994) 1.59
GATA4 haploinsufficiency in patients with interstitial deletion of chromosome region 8p23.1 and congenital heart disease. Am J Med Genet (1999) 1.59
Mutations in the NKX2-5 gene in patients with stroke and patent foramen ovale. Clin Neurol Neurosurg (2009) 1.44
A molecular pathway revealing a genetic basis for human cardiac and craniofacial defects. Science (1999) 1.44
High frequency of submicroscopic genomic aberrations detected by tiling path array comparative genome hybridisation in patients with isolated congenital heart disease. J Med Genet (2008) 1.37
A novel GATA4 mutation completely segregated with atrial septal defect in a large Japanese family. J Med Genet (2004) 1.37
Transcription factor neuromancer/TBX20 is required for cardiac function in Drosophila with implications for human heart disease. Proc Natl Acad Sci U S A (2008) 1.36
A gain-of-function TBX20 mutation causes congenital atrial septal defects, patent foramen ovale and cardiac valve defects. J Med Genet (2009) 1.32
Stress-induced dilated cardiomyopathy in a knock-in mouse model mimicking human titin-based disease. J Mol Cell Cardiol (2009) 1.30
Expressivity of Holt-Oram syndrome is not predicted by TBX5 genotype. Am J Hum Genet (2003) 1.26
Mutations in GATA4, NKX2.5, CRELD1, and BMP4 are infrequently found in patients with congenital cardiac septal defects. Am J Med Genet A (2008) 1.23
Alpha-cardiac actin mutations produce atrial septal defects. Hum Mol Genet (2007) 1.21
HrT is required for cardiovascular development in zebrafish. Development (2002) 1.16
Identification and functional analysis of CITED2 mutations in patients with congenital heart defects. Hum Mutat (2005) 1.16
Unraveling the genetic and developmental mysteries of 22q11 deletion syndrome. Trends Mol Med (2003) 1.16
Noncompaction of the ventricular myocardium is associated with a de novo mutation in the beta-myosin heavy chain gene. PLoS One (2007) 1.15
Dominant-negative ALK2 allele associates with congenital heart defects. Circulation (2009) 1.14
T-box transcription factor TBX20 mutations in Chinese patients with congenital heart disease. Eur J Med Genet (2008) 1.08
Holt-Oram syndrome: a new mutation in the TBX5 gene in two unrelated families. Ann Genet (2003) 1.06
[Adult patients with congenital heart abnormalities: present and future]. Dtsch Med Wochenschr (2005) 1.04
Characterization of TBX20 in human hearts and its regulation by TFAP2. J Cell Biochem (2008) 1.03
Self-fabricated fenestrated Amplatzer occluders for transcatheter closure of atrial septal defect in patients with left ventricular restriction: midterm results. Clin Res Cardiol (2006) 1.02
Progressive AV-block and anomalous venous return among cardiac anomalies associated with two novel missense mutations in the CSX/NKX2-5 gene. Hum Mutat (2002) 1.02
Novel point mutation in the cardiac transcription factor CSX/NKX2.5 associated with congenital heart disease. Circ J (2002) 1.02
GATA4 mutations in 486 Chinese patients with congenital heart disease. Eur J Med Genet (2008) 1.01
Expanding the spectrum of TBX5 mutations in Holt-Oram syndrome: detection of two intragenic deletions by quantitative real time PCR, and report of eight novel point mutations. Hum Mutat (2006) 0.97
CRELD1 and GATA4 gene analysis in patients with nonsyndromic atrioventricular canal defects. Am J Med Genet A (2005) 0.95
Sarcomere mutations in cardiogenesis and ventricular noncompaction. Trends Cardiovasc Med (2009) 0.94
Holt-Oram syndrome is a genetically heterogeneous disease with one locus mapping to human chromosome 12q. Nat Genet (1994) 0.92
[Medical guideline for the treatment of adults with congenital heart abnormalities of the German-Austrian-Swiss Cardiology Specialty Society]. Clin Res Cardiol (2008) 0.90
GATA4 and NKX2.5 gene analysis in Chinese Uygur patients with congenital heart disease. Chin Med J (Engl) (2009) 0.90
Familial congenital heart disease, progressive atrioventricular block and the cardiac homeobox transcription factor gene NKX2.5: identification of a novel mutation. Clin Res Cardiol (2006) 0.89
Holt-Oram syndrome with right lung agenesis caused by a de novo mutation in the TBX5 gene. Am J Med Genet A (2007) 0.89
Detection of a large TBX5 deletion in a family with Holt-Oram syndrome. J Med Genet (2001) 0.89
Contiguous hemizygous deletion of TBX5, TBX3, and RBM19 resulting in a combined phenotype of Holt-Oram and ulnar-mammary syndromes. Am J Med Genet A (2006) 0.88
Can recent insights into cardiac development improve our understanding of congenitally malformed hearts? Clin Anat (2009) 0.88
Quantitative trait loci modifying cardiac atrial septal morphology and risk of patent foramen ovale in the mouse. Circ Res (2006) 0.88
Screening of 99 Danish patients with congenital heart disease for GATA4 mutations. Genet Test (2006) 0.87
Knockdown of alpha myosin heavy chain disrupts the cytoskeleton and leads to multiple defects during chick cardiogenesis. J Anat (2009) 0.87
A novel stop mutation truncating critical regions of the cardiac transcription factor NKX2-5 in a large family with autosomal-dominant inherited congenital heart disease. Clin Res Cardiol (2007) 0.87
Identification of new mutations in the TBX5 gene in patients with Holt-Oram syndrome. Heart (2005) 0.84
Familial atrial septal defect and atrioventricular conduction disturbance associated with a point mutation in the cardiac homeobox gene CSX/NKX2-5 in a Japanese patient. Jpn Circ J (1999) 0.83
Atrial Fibrillation and Other Clinical Manifestations of Altered TBX5 Dosage in Typical Holt-Oram Syndrome. Circ Res (2008) 0.81
Familial recurrence of congenital heart disease in patients with ostium secundum atrial septal defect. Eur Heart J (2005) 0.81
Two novel missense mutations of GATA4 gene in Chinese patients with sporadic congenital heart defects. Zhonghua Yi Xue Yi Chuan Xue Za Zhi (2006) 0.80
Risk factors for atrial septal defect. Eur J Epidemiol (1992) 0.80
A translocation at 12q2 refines the interval containing the Holt-Oram syndrome 1 gene. Am J Hum Genet (1996) 0.77
Mutations in sarcomere protein genes in left ventricular noncompaction. Circulation (2008) 2.93
Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study. J Am Coll Cardiol (2012) 2.28
Integrated assessment of diastolic and systolic ventricular function using diagnostic cardiac magnetic resonance catheterization: validation in pigs and application in a clinical pilot study. JACC Cardiovasc Imaging (2009) 2.25
Assessment of diffuse myocardial fibrosis in rats using small-animal Look-Locker inversion recovery T1 mapping. Circ Cardiovasc Imaging (2011) 2.21
Mutations in the human muscle LIM protein gene in families with hypertrophic cardiomyopathy. Circulation (2003) 2.12
Remodelling of the right ventricle after early pulmonary valve replacement in children with repaired tetralogy of Fallot: assessment by cardiovascular magnetic resonance. Eur Heart J (2005) 2.10
Intubation depth markings allow an improved positioning of endotracheal tubes in children. Can J Anaesth (2005) 2.06
RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing. Nat Med (2012) 1.97
Dysfunction of dysferlin-deficient hearts. J Mol Med (Berl) (2007) 1.89
Fine mapping of the 1p36 deletion syndrome identifies mutation of PRDM16 as a cause of cardiomyopathy. Am J Hum Genet (2013) 1.87
Percutaneous tricuspid valve replacement in congenital and acquired heart disease. J Am Coll Cardiol (2011) 1.74
Novel correlations between the genotype and the phenotype of hypertrophic and dilated cardiomyopathy: results from the German Competence Network Heart Failure. Eur J Heart Fail (2011) 1.70
Magnetic resonance imaging-guided balloon angioplasty of coarctation of the aorta: a pilot study. Circulation (2006) 1.69
Extracorporeal membrane oxygenation for intraoperative cardiac support in children with congenital heart disease. Interact Cardiovasc Thorac Surg (2010) 1.62
A new miniaturized cardiopulmonary bypass system reduces transfusion requirements during neonatal cardiac surgery: initial experience in 13 consecutive patients. J Thorac Cardiovasc Surg (2008) 1.61
Contrast-enhanced magnetic resonance angiography of the great arteries in patients with congenital heart disease: an accurate tool for planning catheter-guided interventions. Int J Cardiovasc Imaging (2005) 1.61
Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J (2010) 1.58
Composite polymorphisms in the ryanodine receptor 2 gene associated with arrhythmogenic right ventricular cardiomyopathy. Cardiovasc Res (2006) 1.58
Absence of pulmonary artery growth after fontan operation and its possible impact on late outcome. Ann Thorac Surg (2009) 1.55
Cardiac energetics correlates to myocardial hypertrophy in Friedreich's ataxia. Ann Neurol (2003) 1.54
Right axillary incision: a cosmetically superior approach to repair a wide range of congenital cardiac defects. J Thorac Cardiovasc Surg (2005) 1.53
Carotid-subclavian artery index: new echocardiographic index to detect coarctation in neonates and infants. Ann Thorac Surg (2005) 1.52
Myocardial systolic and diastolic consequences of left ventricular mechanical dyssynchrony in heart failure with normal left ventricular ejection fraction. Eur Heart J Cardiovasc Imaging (2012) 1.49
Hypertrophic cardiomyopathy in a Portuguese population: mutations in the myosin-binding protein C gene. Rev Port Cardiol (2005) 1.47
Calcineurin in human heart hypertrophy. Circulation (2002) 1.47
Feasibility and efficacy of stent redilatation in aortic coarctation. Catheter Cardiovasc Interv (2008) 1.45
Upper cavo-pulmonary anastomosis by transcatheter technique. Catheter Cardiovasc Interv (2012) 1.44
Percutaneous pulmonary valve implantation: two-centre experience with more than 100 patients. Eur Heart J (2011) 1.44
Connective tissue growth factor overexpression in cardiomyocytes promotes cardiac hypertrophy and protection against pressure overload. PLoS One (2009) 1.43
SDF-1α as a therapeutic stem cell homing factor in myocardial infarction. Pharmacol Ther (2010) 1.42
[Familial dilated cardiomyopathy]. Herz (2005) 1.42
Modified Nikaidoh procedure for the correction of complex forms of transposition of the great arteries with ventricular septal defect and left ventricular outflow tract obstruction: mid-term results. Eur J Cardiothorac Surg (2013) 1.40
Mitral valve repair for infective endocarditis in children. Ann Thorac Surg (2007) 1.39
Flow-sensitive four-dimensional cine magnetic resonance imaging for offline blood flow quantification in multiple vessels: a validation study. J Magn Reson Imaging (2010) 1.37
A gain-of-function TBX20 mutation causes congenital atrial septal defects, patent foramen ovale and cardiac valve defects. J Med Genet (2009) 1.32
The role of stents in the treatment of congenital heart disease: Current status and future perspectives. Ann Pediatr Cardiol (2009) 1.29
Covered Cheatham-platinum stents for aortic coarctation: early and intermediate-term results. J Am Coll Cardiol (2006) 1.26
Mutations in the sarcomere gene MYH7 in Ebstein anomaly. Circ Cardiovasc Genet (2010) 1.24
Mutations in GATA4, NKX2.5, CRELD1, and BMP4 are infrequently found in patients with congenital cardiac septal defects. Am J Med Genet A (2008) 1.23
Sarcomere gene mutations in isolated left ventricular noncompaction cardiomyopathy do not predict clinical phenotype. Circ Cardiovasc Genet (2011) 1.21
A DNA resequencing array for pathogenic mutation detection in hypertrophic cardiomyopathy. Hum Mutat (2008) 1.21
Identification and functional analysis of CITED2 mutations in patients with congenital heart defects. Hum Mutat (2005) 1.16
Expression profiling of human idiopathic dilated cardiomyopathy. Cardiovasc Res (2003) 1.14
Systematic analysis of the regulatory and essential myosin light chain genes: genetic variants and mutations in hypertrophic cardiomyopathy. Eur J Hum Genet (2002) 1.13
Beyond the sarcomere: CSRP3 mutations cause hypertrophic cardiomyopathy. Hum Mol Genet (2008) 1.13
ErbB2 pathways in heart and neural diseases. Trends Cardiovasc Med (2003) 1.12
Systemic-to-pulmonary collateral flow in patients with palliated univentricular heart physiology: measurement using cardiovascular magnetic resonance 4D velocity acquisition. J Cardiovasc Magn Reson (2012) 1.12
Identification of mutational hot spots in LMNA encoding lamin A/C in patients with familial dilated cardiomyopathy. Basic Res Cardiol (2008) 1.12
First experiences with the HeartWare ventricular assist system in children. Ann Thorac Surg (2011) 1.11
Left atrial systolic and diastolic dysfunction in heart failure with normal left ventricular ejection fraction. J Am Soc Echocardiogr (2011) 1.10
Cardiac output measurement in children: comparison of the Ultrasound Cardiac Output Monitor with thermodilution cardiac output measurement. Intensive Care Med (2008) 1.08
Myocardial systolic and diastolic performance derived by 2-dimensional speckle tracking echocardiography in heart failure with normal left ventricular ejection fraction. Circ Heart Fail (2012) 1.07
Genetic deletion of arginine 14 in phospholamban causes dilated cardiomyopathy with attenuated electrocardiographic R amplitudes. Heart Rhythm (2009) 1.07
Cardiovascular magnetic resonance of myocardial edema using a short inversion time inversion recovery (STIR) black-blood technique: diagnostic accuracy of visual and semi-quantitative assessment. J Cardiovasc Magn Reson (2012) 1.05
Usefulness of Doppler myocardial imaging for identification of mutation carriers of familial hypertrophic cardiomyopathy. Am J Cardiol (2002) 1.05
Comparison of different near-infrared spectroscopic cerebral oxygenation indices with central venous and jugular venous oxygenation saturation in children. Paediatr Anaesth (2008) 1.04
Effects of moderate and deep hypothermia on RNA-binding proteins RBM3 and CIRP expressions in murine hippocampal brain slices. Brain Res (2013) 1.03
Characterization of TBX20 in human hearts and its regulation by TFAP2. J Cell Biochem (2008) 1.03
Hypothermia downregulates inflammation but enhances IL-6 secretion by stimulated endothelial cells. Cryobiology (2008) 1.02
Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients. J Heart Lung Transplant (2008) 1.01
Pulmonary vascular resistance, collateral flow, and ventricular function in patients with a Fontan circulation at rest and during dobutamine stress. Circ Cardiovasc Imaging (2010) 1.00
Novel sequence variants in dysferlin-deficient muscular dystrophy leading to mRNA decay and possible C2-domain misfolding. Hum Mutat (2006) 1.00
Doubly heterozygous LMNA and TTN mutations revealed by exome sequencing in a severe form of dilated cardiomyopathy. Eur J Hum Genet (2013) 1.00
Atrial septal defect: waiting for symptoms remains an unsolved medical anachronism. Eur Heart J (2010) 0.99
Repair of anomalous origin of the left coronary artery from the pulmonary artery in infants and children. J Thorac Cardiovasc Surg (2011) 0.99
Unequal allelic expression of wild-type and mutated β-myosin in familial hypertrophic cardiomyopathy. Basic Res Cardiol (2011) 0.98
Physical models aiding in complex congenital heart surgery. Ann Thorac Surg (2008) 0.97
Pediatric heart transplantation: 23-year single-center experience. Eur J Cardiothorac Surg (2011) 0.96
Four-dimensional velocity-encoded magnetic resonance imaging improves blood flow quantification in patients with complex accelerated flow. J Magn Reson Imaging (2012) 0.96
A missense variant in desmoglein-2 predisposes to dilated cardiomyopathy. Mol Genet Metab (2008) 0.95
A myomesin mutation associated with hypertrophic cardiomyopathy deteriorates dimerisation properties. Biochem Biophys Res Commun (2011) 0.94
Hypertrophic cardiomyopathy-related beta-myosin mutations cause highly variable calcium sensitivity with functional imbalances among individual muscle cells. Am J Physiol Heart Circ Physiol (2004) 0.94
Cardiac alpha-myosin (MYH6) is the predominant sarcomeric disease gene for familial atrial septal defects. PLoS One (2011) 0.93
Evaluation of a new combined SpO2/PtcCO2 sensor in anaesthetized paediatric patients. Paediatr Anaesth (2003) 0.92
Continuous, non-invasive techniques to determine cardiac output in children after cardiac surgery: evaluation of transesophageal Doppler and electric velocimetry. J Clin Monit Comput (2008) 0.92
S100B modulates IL-6 release and cytotoxicity from hypothermic brain cells and inhibits hypothermia-induced axonal outgrowth. Neurosci Res (2007) 0.91
Mutations in the cardiac transcription factor GATA4 in patients with lone atrial fibrillation. Eur J Med Genet (2010) 0.91
Coagulation management in pediatric mechanical circulatory support. ASAIO J (2007) 0.91
Single-center experience with treatment of cardiogenic shock in children by pediatric ventricular assist devices. J Thorac Cardiovasc Surg (2011) 0.91
Mechanisms of hypothermia-induced cell protection mediated by microglial cells in vitro. Eur J Neurosci (2010) 0.91
Influence of intravenous sildenafil on cerebral oxygenation measured by near-infrared spectroscopy in infants after cardiac surgery. Pediatr Res (2006) 0.90
Functional analysis of the components of the right ventricle in the setting of tetralogy of Fallot. Circ Cardiovasc Imaging (2008) 0.88
A network against failing hearts--introducing the German "Competence Network Heart Failure". Int J Cardiol (2009) 0.88
Novel mutations in the sarcomeric protein myopalladin in patients with dilated cardiomyopathy. Eur J Hum Genet (2012) 0.88
Hypothermia-induced neurite outgrowth is mediated by tumor necrosis factor-alpha. Brain Pathol (2010) 0.88
Clopidogrel in infants with systemic-to-pulmonary-artery shunts. N Engl J Med (2013) 0.87
Gender-specific differences in major cardiac events and mortality in lamin A/C mutation carriers. Eur J Heart Fail (2012) 0.87
Management of pediatric patients after implantation of the Berlin Heart EXCOR ventricular assist device. ASAIO J (2006) 0.87